Chief Executive Officer
Tue, Mar 21, 2023
Mar 21
exercised or converted securities in APLS
30,000 shares @ $2.67
Increased holdings by +2.60%
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology